INS and type 1 diabetes mellitus: Such effort is in line with the “β-cell fragility” model, which proposes that a genetically determined increased risk of β-cell death or insulin secretion dysfunction may contribute to the risk of developing either T2D or T1D, especially in the presence of immunological and/or metabolic stress factors [71–74].